Mary Kay Fenton
2022 - Tourmaline Bio
In 2022, Mary Kay Fenton earned a total compensation of $2.2M as Former Interim Chief Executive Officer and President and Chief Financial Officer at Tourmaline Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $131,783 |
|---|---|
| Option Awards | $1,301,440 |
| Salary | $455,000 |
| Stock Awards | $308,800 |
| Other | $12,200 |
| Total | $2,209,223 |
Fenton received $1.3M in option awards, accounting for 59% of the total pay in 2022.
Fenton also received $131.8K in non-equity incentive plan, $455K in salary, $308.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Mary Kay Fenton's compensation ranked 1,606th out of 5,506 executives tracked by ExecPay. In other words, Fenton earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,606 out of 5,506 | 71st |
Division Manufacturing | 823 out of 2,985 | 72nd |
Major group Chemicals And Allied Products | 321 out of 1,340 | 76th |
Industry group Drugs | 297 out of 1,243 | 76th |
Industry Biological Products, Except Diagnostic Substances | 75 out of 287 | 74th |
Source: SEC filing on April 19, 2024.
Fenton's colleagues
We found two more compensation records of executives who worked with Mary Kay Fenton at Tourmaline Bio in 2022.